Antigen-specific CD4+ T cell responses were analyzed in mice primed with the chimeric TB vaccine antigen H56 administered alone or in combination with the liposome system CAF01, and boosted after 4 weeks with H56 antigen alone (Figure 1). This evidence concerns the gene CD4 and tuberculosis.